Alia Therapeutics

Safe and durable gene editing solutions for patients

Alia Therapeutics was founded in 2018, is headquartered in Trento, Italy, lists 1–10 employees, and has $7.0M in recorded funding across 2 rounds.

Headquarters
Trento
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$7.0M
Last Round
$2.2M Extension RoundFeb 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa, a leading cause of inherited blindness worldwide. The company leverages a proprietary CRISPR platform featuring novel, next-generation enzymes discovered in-house that enable a modular, mutation-agnostic approach using a single AAV vector. Founded in 2018 out of pioneering research at Trento University, Alia aims to transform treatment of inherited blindness by delivering scalable, precise, and durable gene editing solutions.

Summary

Alia Therapeutics is a Biotech company based in Trento, Italy, founded in 2018. It lists 1–10 employees. It has raised $7.0M in total across 2 rounds, most recently a $2.2M Extension Round in Feb 2021. Investors include Sofinnova Partners, Bpifrance and Indaco Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundFeb 2021
$2.2M

Sign up to see all 2 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alia-therapeutics"><img src="https://indexed.vc/api/badge/company/alia-therapeutics" alt="Alia Therapeutics on Indexed.vc" width="260" height="76" /></a>